{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:36:50Z","timestamp":1762418210078,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.remn.2020.12.001","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T23:01:45Z","timestamp":1612566105000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enfermedad relacionada con IgG4"],"prefix":"10.1016","volume":"40","author":[{"given":"M.","family":"Sim\u00f3-Perdig\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Martinez-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2020.12.001_bib0230","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","article-title":"Autoimmune pancreatitis is a systemic autoimmune disease","volume":"98","author":"Kamisawa","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.remn.2020.12.001_bib0235","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmunedisease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.remn.2020.12.001_bib0240","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/ajg.2009.325","article-title":"Evaluation and management of autoinmune pancreatitis: Experience at a large US center","volume":"104","author":"Raina","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.remn.2020.12.001_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A novel clinical entity IgG4-related disease (IgG4RD): General concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Modern Rheumatology\/the Japan Rheumatism Association."},{"key":"10.1016\/j.remn.2020.12.001_bib0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/cgh.2003.50016","article-title":"Idiopathic tumefactive chronic pancreatitis: Clinical profile, histology, and natural history after resection","volume":"1","author":"Yadav","year":"2003","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity."},{"key":"10.1016\/j.remn.2020.12.001_bib0260","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1136\/annrheumdis-2012-201477","article-title":"Interleukin-21 contributesto germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"71","author":"Maehara","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0265","first-page":"679","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J AllergyClinImmunol."},{"key":"10.1016\/j.remn.2020.12.001_bib0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarkerfor IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.2000.1687","article-title":"Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts","volume":"204","author":"Song","year":"2000","journal-title":"Cell Immunol."},{"key":"10.1016\/j.remn.2020.12.001_bib0280","doi-asserted-by":"crossref","first-page":"e1275","DOI":"10.1097\/MD.0000000000001275","article-title":"IgG4-related disease: Results from a Multicenter Spanish Registry","volume":"94","author":"Fern\u00e1ndez-Codina","year":"2015","journal-title":"Medicine (Baltimore)."},{"unstructured":"Wallace Z.S. IgG4-related disease: Clinical and laboratoryfeatures in 125 patients. Arthritis Rheumatol. Hoboken, NJ. 2015. 1-30.","key":"10.1016\/j.remn.2020.12.001_bib0285"},{"key":"10.1016\/j.remn.2020.12.001_bib0290","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.remn.2020.12.001_bib0295","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol Mech Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgEelevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"AllergyEur J Allergy Clin Immunol."},{"key":"10.1016\/j.remn.2020.12.001_bib0305","first-page":"1","article-title":"IgG4-related disease in Italy: Clinical features and outcomes of a large cohort of patients","volume":"9742","author":"Campochiaro","year":"2015","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0310","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: A prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.remn.2020.12.001_bib0315","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: Analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","article-title":"Chronic sclerosing sialadenitis (K\u00fcttner tumor) isan IgG4-associated disease","volume":"34","author":"Geyer","year":"2010","journal-title":"Am J SurgPathol."},{"key":"10.1016\/j.remn.2020.12.001_bib0325","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.3748\/wjg.v20.i44.16559","article-title":"Diagnosis of autoimmune pancreatitis","volume":"20","author":"Matsubayashi","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.remn.2020.12.001_bib0330","first-page":"8","article-title":"Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients","volume":"400","author":"Fern\u00e1ndez-Codina","year":"2014","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.remn.2020.12.001_bib0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.remn.2020.12.001_bib0340","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v19.i43.7661","article-title":"Diagnosis of IgG4-related sclerosingcholangitis","volume":"19","author":"Nakazawa","year":"2013","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.remn.2020.12.001_bib0345","doi-asserted-by":"crossref","first-page":"e3344","DOI":"10.1097\/MD.0000000000003344","article-title":"Large vessel involvement by IgG4-related disease","volume":"95","author":"Perugino","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.remn.2020.12.001_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.remn.2020.12.001_bib0355","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol."},{"key":"10.1016\/j.remn.2020.12.001_bib0360","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with18F-FDG PET\/CT: A prospectivecohortstudy","volume":"41","author":"Zhang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2020.12.001_bib0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emissiontomography\/computedtomographyforstaging and evaluation of treatment response in IgG4-related disease: A retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.remn.2020.12.001_bib0370","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/RLU.0000000000001153","article-title":"Utility of FDG PET\/CT fordifferential diagnosis of patientsclinicallysuspected of IgG4- relateddisease","volume":"41","author":"Lee","year":"2016","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2020.12.001_bib0375","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/rheumatology\/kex234","article-title":"Quantitative measurement of 18F-FDG PET\/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease","volume":"56","author":"Berti","year":"2017","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.remn.2020.12.001_bib0380","first-page":"579","article-title":"Total lesi\u00f3n glycolysis as an IgG4-related disease activity marker","volume":"25","author":"Nakatsuka","year":"2015","journal-title":"Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0385","first-page":"119","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0390","article-title":"Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: A single-center retrospective study","author":"Yoo","year":"2020","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0395","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1536\/ihj.13-321","article-title":"IgG4-related cardiovascular disorders","volume":"55","author":"Tajima","year":"2014","journal-title":"Int Heart J."},{"key":"10.1016\/j.remn.2020.12.001_bib0400","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-017-0268-1","article-title":"Characteristics of immunoglobulin G4- related aortitis\/periaortitis and periarteritis on fluorodeoxyglucose positr\u00f3n emisi\u00f3n tomography\/computed tomography co-registered with contrast-enhanced computed tomography","volume":"7","author":"Yabusaki","year":"2017","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.remn.2020.12.001_bib0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/MNM.0000000000001238","article-title":"Features of IgG4-related lung disease on 18F-FDG PET\/computed tomography imaging","volume":"41","author":"Xiao","year":"2020","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.remn.2020.12.001_bib0410","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0b013e3181ee63ce","article-title":"IgG4-related sclerosing disease: A critical appraisal of an evolving clinicopathologic entity","volume":"17","author":"Cheuk","year":"2010","journal-title":"Adv Anat Pathol."},{"key":"10.1016\/j.remn.2020.12.001_bib0415","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MPA.0b013e3181bd64a1","article-title":"Clinical significance of extrapancreatic lesions in autoimmune pancreatitis","volume":"39","author":"Naitoh","year":"2010","journal-title":"Pancreas."},{"key":"10.1016\/j.remn.2020.12.001_bib0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criterio for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0425","first-page":"1","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism. Classification criterio for IgG4-related disease","volume":"0","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0013","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD Responder Index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol."},{"key":"10.1016\/j.remn.2020.12.001_bib0435","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance Statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken NJ)."},{"key":"10.1016\/j.remn.2020.12.001_bib0440","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximabfor IgG4-related disease: A prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.remn.2020.12.001_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.remn.2020.12.001_bib0450","article-title":"Fibroblast activation protein targeted PET\/CT with (68)Ga-FAPI for imaging IgG4-related disease: Comparis on to (18)F-FDG PET\/CT","author":"Luo","year":"2020","journal-title":"J Nucl Med."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X21000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X21000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:33:49Z","timestamp":1762418029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X21000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2253654X21000019"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2020.12.001","relation":{},"ISSN":["2253-654X"],"issn-type":[{"type":"print","value":"2253-654X"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enfermedad relacionada con IgG4","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}